Next Article in Journal
In Silico Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa
Next Article in Special Issue
Antimicrobial Activity of Five Essential Oils against Bacteria and Fungi Responsible for Urinary Tract Infections
Previous Article in Journal
Hydrophilic Interaction Liquid Chromatography-Electrospray Ionization Mass Spectrometry for Therapeutic Drug Monitoring of Metformin and Rosuvastatin in Human Plasma
Previous Article in Special Issue
Antibacterial Activity of Emulsified Pomelo (Citrus grandis Osbeck) Peel Oil and Water-Soluble Chitosan on Staphylococcus aureus and Escherichia coli
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 23
Issue 7
10.3390/molecules23071549
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils

by
Chelsea N. Powers
1,
Jessica L. Osier
1,
Robert L. McFeeters
1,
Carolyn Brianne Brazell
2,
Emily L. Olsen
2,
Debra M. Moriarity
2,
Prabodh Satyal
3 and
William N. Setzer
1,3,*
1
Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA
2
Department of Biological Sciences, University of Alabama in Huntsville, Huntsville, AL 35899, USA
3
Aromatic Plant Research Center, 615 St. George Square Court, Suite 300, Winston-Salem, NC 27103, USA
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(7), 1549; https://doi.org/10.3390/molecules23071549
Submission received: 18 June 2018 / Revised: 25 June 2018 / Accepted: 26 June 2018 / Published: 27 June 2018
(This article belongs to the Special Issue Essential Oils as Antimicrobial and Anti-infectious Agents)
Browse Figures
Versions Notes

Abstract

:
There is an urgent and unmet need for new antifungal therapies. Global fungal infection rates continue to rise and fungal infections pose increasing burdens on global healthcare systems. Exacerbating the situation, the available antifungal therapeutic arsenal is limited and development of new antifungals has been slow. Current antifungals are known for unwanted side effects including nephrotoxicity and hepatotoxicity. Thus, the need for new antifungals and new antifungal targets is urgent and growing. A collection of 60 commercially-available essential oils has been screened for antifungal activity against Aspergillus niger, Candida albicans, and Cryptococcus neoformans, as well as for cytotoxic activity against MCF-7 and MDA-MB-231 human breast tumor cell lines; the chemical compositions of the essential oils have been determined by gas chromatography-mass spectrometry (GC-MS). Ten essential oils showed remarkable antifungal and cytotoxic activities: Indian, Australian, and Hawaiian sandalwoods; melissa; lemongrass; cilantro; cassia; cinnamon; patchouli; and vetiver.

Graphical Abstract

1. Introduction

Fungi are ubiquitous in nature. Of the estimated 1.5 million species of fungi [1], there are approximately 100 species that cause human infection [2]. These infections include aspergillosis, candidiasis, and cryptococcosis, among others [3]. Invasive fungal infections from these opportunistic pathogens have been increasing in recent decades, causing substantial morbidity and mortality [2,4]. The most common Aspergillus species causing pulmonary aspergillosis is A. fumigatus, but A. flavus, A. terreus, and A. niger can also cause Aspergillus lung disease, particularly in immunosuppressed individuals [5]. Likewise, the principle agents of candidiasis are Candida albicans, C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei [6]. Cryptococcus neoformans is the main fungal species responsible for cryptococcosis, but Cryptococcus taxonomy has undergone several revisions [7]. Treatment options for invasive fungal infections include amphotericin B, as well as several azole compounds, such as fluconazole and itraconazole [8]. However, there have been severe side effects associated with these antifungal agents [8], and antifungal resistance continues to increase [9].
Essential oils are complex mixtures of volatile compounds derived principally from higher plants [10]. These materials have been used to treat human infections and other maladies for centuries. The biological activities associated with essential oils depend on the compositions, both the concentrations of the major components and the possible synergistic interactions with minor components. In this report, we present the antifungal screening of a collection of 60 essential oils obtained from commercial sources against Aspergillus niger, Candida albicans, and Cryptococcus neoformans. In addition, the essential oils were also screened against two human breast tumor cell lines, MCF-7 (estrogen receptor positive breast adenocarcinoma) and MDA-MB-231 (estrogen receptor negative breast adenocarcinoma).

2. Results

The antifungal and cytotoxicity screening results are summarized in Table 1. The most active essential oils, both in terms of antifungal activity and cytotoxic activity, were the sandalwood species (Santalum album, S. austrocaledonicum, and S. paniculatum), rich in santalols; cassia (Cinnamomum cassia) and cinnamon (C. zeylanicum), both dominated by cinnamaldehyde; lemongrass (Cymbopogon flexuosus), melissa (Melissa officinalis), and cilantro (Coriandrum sativum leaf oil), which were dominated by aldehydes; patchouli (Pogostemon cablin), rich in patchouli alcohol; and vetiver (Vetiveria zizanoides), with isovalencenol and khusimol as major components. Of the fungal species tested, Cryptococcus neoformans was the most susceptible and Candida albicans was the least sensitive. Both breast tumor cells lines showed similar activities and correlated well with C. neoformans antifungal activity.
A hierarchical cluster analysis (Figure 1) revealed four apparent clusters based on compositions and bioactivities: (1) a largely inactive cluster that is dominated by oxygenated monoterpenoids; (2) an inactive cluster with aromatics as the predominant chemical class; (3) a largely inactive cluster, dominated by monoterpene and sesquiterpene hydrocarbons; and (4) the biologically active cluster, which is rich in oxygenated sesquiterpenoids and aldehydes.

3. Discussion

Cluster 1 is characterized as being composed largely of oxygenated monoterpenoids and is relatively inactive. Notable members of cluster 1 are Melaleuca alternifolia, Salvia officinalis, Eucalyptus radiata, Origanum vulgare, and Thymus vulgaris. Oxygenated monoterpenoids such as linalool, terpinen-4-ol, α-terpineol, borneol, camphor, or thujones are largely inactive against fungi, as well as tumor cells [11,12,13]. On the other hand, 1,8-cineole has shown moderate antifungal activity [11,14], and the activity of 1,8-cineole is likely responsible for the moderate antifungal activity of Eucalyptus radiata essential oil (minimum inhibitory concentrations (MIC) = 313 and 156 μg/mL against A. niger and C. neoformans, respectively). Tea tree (Melaleuca alternifolia) oil had previously shown only marginal antifungal activity, attributed to the active components terpinen-4-ol and and α-terpineol [15], and in this current work, we find only marginal antifungal activity (MIC = 625 μg/mL). In agreement with an earlier work [16], Salvia officinalis essential oil showed only marginal antifungal activity (MIC ≥ 625 μg/mL).
Interestingly, thyme (Thymus vulgaris; 43.9% thymol and 14.4% carvacrol) essential oil was not cytotoxic in this study. Oregano oil (Origanum vulgare; 74.2% carvacrol), on the other hand, was moderately cytotoxic (IC50 = 35.3 and 60.1 μg/mL on MCF-7 and MDA-MB-231 cells, respectively). Both thyme and oregano oils showed similar antifungal profiles with MIC = 156, 313, and 78 μg/mL against A. niger, C. albicans, and C. neoformans, respectively. The phenolic monoterpenoids, carvacrol and thymol, are likely responsible for the observed antifungal activities [17,18,19]. The biological activity of thyme essential oil depends on the thymol concentration; there are several chemotypes of thyme with vastly different concentrations of thymol [20].
Cluster 2 contained only three essential oils, all dominated by aromatic constituents: Birch (Betula lenta, 99.9% methyl salicylate), wintergreen (Gualtheria fragrantissima, 99.7% methyl salicylate), and clove (Eugenia caryophyllata, syn. Syzygium aromaticum, 80.6% eugenol and 10.5% eugenyl acetate). Neither birch nor wintergreen oils were antifungal or cytotoxic. However, clove oil was moderately antifungal (MIC = 156, 313, and 156 μg/mL against A. niger, C. albicans, and C. neoformans, respectively). Clove oil had previously demonstrated moderate antifungal activity against A. niger [21] and C. albicans [22], which can be attributed to the high concentration of eugenol [23].
Cluster 3 can be subdivided into a sub-cluster rich in monoterpene hydrocarbons (3a) and a sub-cluster with both monoterpene hydrocarbons and sesquiterpene hydrocarbons (3b). Sub-cluster 3a is made up of gymnosperm essential oils and the Citrus essential oils and are, by and large, inactive.
Sub-cluster 3b, on the other hand, has significant concentrations of sesquiterpenoids and generally showed moderate cytotoxic activity. Thus, for example, Cistus ladanifer essential oil had IC50 values of 36.6 and 46.3 μg/mL against MCF-7 and Hs578T cell lines; copaiba oils, rich in β-caryophyllene, showed moderate cytotoxic activities on both MCF-7 and MDA-MB-231 cells (IC50 values range from 22.7 to 67.2 μg/mL). Frankincense (Boswellia carteri) essential oil is also rich in β-caryophyllene and showed comparable cytotoxic activity. Sesquiterpene hydrocarbons, such as β-caryophyllene and α-humulene, have shown moderate cytotoxic activity against several human tumor cell lines [11,13,24]; the relatively high concentrations of sesquiterpene hydrocarbons in the essential oils of sub-cluster 3b may account for the observed moderate cytotoxicities.
Cedarwood oil (the wood essential oil of Juniperus virginiana) had previously shown excellent cytotoxic activities against MCF-7 (IC50 = 3.99 μg/mL) and MDA-MB-231 (IC50 = 4.32 μg/mL) [25]. In our current study, however, J. virginiana wood oil was less active against these two cell lines (IC50 = 37.2 and 35.7 μg/mL, respectively), and showed only marginal antifungal activity (MIC = 625, 625, and 313 μg/mL against A. niger, C. albicans, and C. neoformans, respectively).
Cluster 4 is made up of the essential oils that showed both antifungal and cytotoxic activities. The sandalwood essential oils were particularly active against C. neoformans (MIC = 20 μg/mL) and MCF-7 cells (IC50 = 9.4, 9.5, and 13.3 μg/mL for S. album, S. austrocaledonicum, and S. paniculatum, respectively). Sandalwood oils were less effective against A. niger (MIC = 156–313 μg/mL) and only marginally active against C. albicans (MIC = 625 μg/mL), but still exhibited cytotoxic activity to MDA-MB-231 cells (IC50 = 19–24 μg/mL) and showed similar activities against Hep-G2 cells (IC50 = 14.2, 22.2, and 29.6 μg/mL for S. album, S. austrocaledonicum, and S. paniculatum, respectively).
Sandalwood oil (species not reported) had shown antifungal activity against C. neoformans with MIC of 100 μg/mL [26]. Indian sandalwood (S. album) had previously shown only marginal activity against C. albicans [27] with MIC values of around 600 μg/mL [28,29], consistent with this current investigation. Santalum album essential oil had previously demonstrated in vitro cytotoxic activity on both MCF-7 and MDA-MB-231 cells [25,30], as well as several other tumor cell lines [31]. The antifungal and cytotoxic activities of sandalwood oils can be attributed to the high concentrations of α- and β-santalols [32,33].
Both Cinnamomum cassia and C. zeylanica are rich in cinnamaldehyde (79.9 and 63.9%, respectively), and this compound is likely responsible for the antifungal (MIC = 20, 78, and 78 μg/mL against C. neoformans, A. niger, and C. albicans, respectively) and cytotoxic activities (IC50 on MCF-7 = 14.0 and 13.3 μg/mL for C. cassia and C. zeylanicum, respectively) observed for these essential oils. Both C. cassia and C. zeylanica have previously shown antifungal activity against A. niger [21,34], C. albicans [35,36], and C. neoformans [37,38], and C. zeylanicum has shown cytotoxic activity to MCF-7 and MDA-MB-231 cells [39]. (E)-Cinnamaldehyde has been shown to be both antifungal [37,40] and cytotoxic [41].
Aldehydes are major components of the essential oils of cilantro (Coriandrum sativum leaf oil, 25.9% (2E)-decenal and 7.9% decanal), lemongrass (Cymbopogon flexuosus, 49.9% geranial and 23.4% neral), and melissa (Melissa officinalis, 30.2% geranial and 23.1% neral). These essential oils showed good antifungal activity against C. neoformans (MIC = 20, 78, and 78 μg/mL, respectively) in addition to cytoxicity (IC50 ≈ 40, 20–30, and 30 μg/mL, respectively). Citral (a mixture of geranial and neral) has demonstrated both antifungal and cytotoxic activities [13,42,43]. In general, aldehydes are electrophilic agents and can react with nucleophilic biological macromolecules, which may account for the biological activities of aldehydes [44,45,46].
Both patchouli (Pogostemon cablin) and vetiver (Vetiveria zizanoides) essential oils showed notable antifungal activity against C. neoformans (MIC = 20 μg/mL), as well as cytotoxic activity against MCF-7 cells (IC50 = 25.0 and 23.9 μg/mL, respectively). Both of these essential oils are rich in sesquiterpene alcohols, patchouli alcohol in P. cablin, and (E)-isovalencenol and khusimol in V. zizanoides. Previous studies on the antifungal activity of patchouli oil showed no activity against Aspergillus spp. [21,47], whereas in this work, patchouli oil showed inhibition against A. niger with MIC of 156 μg/mL. Likewise, vetiver oil inhibited the growth of A. niger and C. albicans (MIC = 78 and 313 μg/mL), but previous reports in the literature showed no activity against these two organisms [21,22].

4. Materials and Methods

4.1. Essential Oils

Commercially available essential oils were obtained from the following sources: dōTERRA International (Pleasant Grove, UT, USA), Améo/Zija International (Lehi, UT, USA), Mountain Rose Herbs (Eugene, OR, USA), and Albert Vielle (Grasse, France). For screening, 1% solutions in dimethylsulfoxide (DMSO) were prepared (i.e., 100 mg essential oil, diluted to 10 g with DMSO).

4.2. Gas Chromatography-Mass Spectrometry

Essential oils obtained from dōTERRA International were analyzed by gas chromatography-mass spectrometry (GC-MS) using a Shimadzu GCMS-QP2010 Ultra operated in the electron impact (EI) mode (electron energy = 70 eV), scan range = 40–400 atomic mass units, scan rate = 3.0 scans/s, and GC-MS solution software version. 4.20 (Shimadzu Scientific Instruments, Columbia, MD, USA). The GC column was a ZB-5 fused silica capillary column (Phenomenex, Torrance, CA, USA) with a (5% phenyl)-polymethylsiloxane stationary phase and a film thickness of 0.25 μm. The carrier gas was helium with a column head pressure of 552 kPa and flow rate of 1.37 mL/min. The injector temperature was 250 °C and the ion source temperature was 200 °C. The GC oven temperature program was programmed for 50 °C initial temperature, temperature increased at a rate of 2 °C/min to 260 °C. A 5% w/v solution of the sample in CH2Cl2 was prepared and 0.1 μL was injected with a splitting mode (30:1). The remaining essential oils (Ameo, Mountain Rose Herbals, Albert Vielle) were analyzed with an Agilent 6890 GC, Agilent 5973 MSD, EI (70 eV); range of 40–400 amu, scan rate of 3.99 scans/s, HP-5ms column (Agilent Technologies, Santa Clara, CA, USA), He carrier gas, head pressure of 92.4 kPa, flow rate of 1.5 mL/min, GC oven temperature program of 60 °C initial temperature, held for 5 min, then increased at 3 °C/min up to 280 °C, 1% solutions of essential oils in CH2Cl2, splitless injection. Identification of the oil components was based on their retention indices determined by reference to a homologous series of n-alkanes, and by comparison of their mass spectral fragmentation patterns with those reported in the literature [48], and stored in our in-house library [49].

4.3. Antifungal Screening

Candida albicans (ATCC 18804) and Cryptococcus neoformans (ATCC 24607) were grown on potato dextrose agar (PDA) for 48 or 72 h, respectively. Three milliliters of potato dextrose broth (PDB) was inoculated with a single colony. These liquid cultures were grown at 37 °C for another 48 or 72 h for microdilution assays. Minimum inhibitory concentrations (MICs) were determined by microdilution in 96-well round bottom plates from triplicates. Briefly, 100-µL aliquots of MOPS (3-(N-morpholino)propanesulfonic acid) buffered RPMI (Roswell Park Memorial Institute) medium pH 7.0 were added to each well. In addition, aliquots of 100 µL of essential oil (1% in DMSO) or the positive and negative controls of 100% DMSO and 100 µM amphotericin B (AMB) and 100% DMSO, respectively, were added to the first row. Each well was serially diluted two-fold down the column excluding the negative control (medium alone). Subsequently, 100 µL of 4 × 103 cells/mL of inoculum in MOPS buffered RPMI were added to each well, resulting in a final concentration of 2 × 103 cells/mL. The microplates were incubated at 37 °C without agitation for 48 or 72 h for C. albicans or C. neoformans, respectively. MIC values were determined visually as the last well with no turbidity by comparison with the positive and negative controls.
Aspergillus niger (ATCC 16888) was grown for seven days at room temperature on potato dextrose agar (PDA) plates. Using an inoculum loop, the spores were gently gathered from the top of the PDA plate and suspended in 1 mL of potato dextrose broth (PDB). Before further use, the spore solution was filtered using sterile cheesecloth. The OD625 was adjusted to 0.15 by dilution with fresh PDB. For screening, 100 μL of MOPS buffered RPMI was added to each well of a 96-well plate. A sample or a control of 100 μL was then added to the first well in each row and serially diluted down the column. Lastly, 100 uL of the adjusted spore solution was added to each well of the plate. The plates were incubated at room temperature for seven days. Amphotericin B was used as a positive control, while DMSO and RPMI media alone were used as negative controls. Inhibition was determined visually by comparing the growth of the positive and negative controls with the samples.

4.4. Cytotoxicity Screening

Cell culturing and cytotoxicity screening were carried out as previously reported [50]. Briefly, MCF-7 and MDA-MB-231 cells were each grown in sterile RPMI 1640 media with l-glutamine, 26 mL of 7.5% sodium bicarbonate per liter medium; 10,000 units penicillin and 10,000 μg/mL streptomycin per liter of medium; and 15 mL of 1 M HEPES per liter medium, buffered with 5.0 N NaOH to pH 7.35. MCF-7 and MDA-MB-231 cells were plated at concentrations of 1.44 × 106 and 1.44 × 104 cells per well, respectively, in 96-well plates in volumes of 100 μL/well. Test samples were diluted in growth medium to a concentration of 0.01% (w/v). Tingenone was used as a positive control; growth medium and DMSO were used as negative controls for each plate. The final concentrations of test samples and tingenone controls were 100 μg/mL. The cells were incubated with the test samples at 37 °C and 5% CO2 for 48 h. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to determine cell viability. The supernatant medium was removed from each well using suction and a solution of MTT solution (1:10 dilution of 5 mg/mL of stock MTT in growth medium) was added to each well, and the plates were incubated for an additional 4 h at 37 °C and 5% CO2. After the incubation period, the medium was carefully aspirated from the wells, and 100 μL of ISO PBS, containing 100 mL isopropyl alcohol, 4.0 μL 5.0 N HCl, and 50.0 mL phosphate-buffered saline, was added to the wells, and the plate was gently shaken to dissolve the crystals. Absorbance was measured using a SpectraMax plate reader at 570 nm and percent viability was determined. For essential oils showing <50% viability, dilutions of the samples (50, 40, 30, 20, and 10 μg/mL) were further assayed. Median inhibitory concentrations (IC50) were determined using the Reed-Muench method [51].

4.5. Hierarchical Cluster Analysis

The chemical classes of the commercial essential oils, along with the antifungal and cytotoxic activities, were used in the cluster analysis. The 60 essential oils were treated as operational taxonomic units (OTUs) and the 12 chemical classes (monoterpene hydrocarbons, oxygenated monoterpenoids, sesquiterpene hydrocarbons, oxygenated sesquiterpenoids, diterpenoids, aromatic compounds, fatty-acid derivatives, aliphatic esters, aldehydes, phenolics, sulfur-containing compounds, and others) and five bioactivities (Aspergillus niger, Candida albicans, Cryptococcus neoformans, MCF-7, and MDA-MB-231) were used to determine the associations between the essential oils using agglomerative hierarchical cluster (AHC) analysis using XLSTAT Premium, version 19.5.47159 (Addinsoft, Paris, France). Dissimilarity was determined using Euclidean distance, and clustering was defined using Ward’s method.

5. Conclusions

Several essential oils have shown notable antifungal activities against opportunistic fungal pathogens. These readily-available materials may add to our treatment options, as agents themselves or as adjuvant therapies, to combat fungal infections. In addition to the antifungal and cytotoxic activities of the essential oils in this study, those essential oil that do not show appreciable cytotoxic activity to human cells may be considered relatively safe for other uses such as cosmetics, flavoring, and aromatherapy.

Author Contributions

Conceptualization, W.N.S.; Data curation, W.N.S.; Formal analysis, R.M., D.M.M., P.S. and W.N.S.; Investigation, C.N.P., J.L.O., C.B.B., E.L.O. and P.S.; Methodology, R.L.M. and D.M.M.; Project administration, W.N.S.; Resources, R.L.M. and D.M.M.; Software, P.S.; Supervision, R.L.M., D.M.M. and W.N.S.; Writing—original draft, W.N.S.; Writing—review & editing, C.N.P., J.L.O., R.L.M., C.B.B., E.L.O. and W.N.S.

Funding

C.N.P was supported, in part, by the National Institutes of Health grant R15GM119052 awarded to R.L.M. P.S. and W.N.S. participated in this work as part of the activities of the Aromatic Plant Research Center (APRC, https://aromaticplant.org/). The authors are grateful to dōTERRA International (https://www.doterra.com/US/en) for financial support of the APRC.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hawksworth, D.L. The magnitude of fungal diversity: The 1.5 million species estimate revisited. Mycol. Res. 2001, 105, 1422–1432. [Google Scholar] [CrossRef]
  2. Horn, F.; Heinekamp, T.; Kniemeyer, O.; Pollmächer, J.; Valiante, V.; Brakhage, A.A. Systems biology of fungal infection. Front. Microbiol. 2012, 3, 108. [Google Scholar] [CrossRef] [PubMed]
  3. Enoch, D.A.; Ludlam, H.A.; Brown, N.M. Invasive fungal infections: A review of epidemiology and management options. J. Med. Microbiol. 2006, 55, 809–818. [Google Scholar] [CrossRef] [PubMed]
  4. Armstrong-James, D.; Meintjes, G.; Brown, G.D. A neglected epidemic: Fungal infections in HIV/AIDS. Trends Microbiol. 2014, 22, 120–127. [Google Scholar] [CrossRef] [PubMed]
  5. Kosmidis, C.; Denning, D.W. The clinical spectrum of pulmonary aspergillosis. Thorax 2015, 70, 270–277. [Google Scholar] [CrossRef] [PubMed]
  6. Antinori, S.; Milazzo, L.; Sollima, S.; Galli, M.; Corbellino, M. Candidemia and invasive candidiasis in adults: A narrative review. Eur. J. Intern. Med. 2016, 34, 21–28. [Google Scholar] [CrossRef] [PubMed]
  7. May, R.C.; Stone, N.R.H.; Wiesner, D.L.; Bicanic, T.; Nielsen, K. Cryptococcus: From environmental saprophyte to global pathogen. Nat. Rev. Microbiol. 2016, 14, 106–117. [Google Scholar] [CrossRef] [PubMed]
  8. Girois, S.B.; Chapuis, F.; Decullier, E.; Revol, B.G.P. Adverse effects of antifungal therapies in invasive fungal infections: Review and meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25, 138–149. [Google Scholar] [CrossRef] [PubMed]
  9. Pfaller, M.A. Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 2012, 125, S3–S13. [Google Scholar] [CrossRef] [PubMed]
  10. Başer, K.H.C.; Buchbauer, G. Handbook of Essential Oils: Science, Technology, and Applications; CRC Press: Boca Raton, FL, USA, 2010. [Google Scholar]
  11. Schmidt, J.M.; Noletto, J.A.; Vogler, B.; Setzer, W.N. Abaco bush medicine: Chemical composition of the essential oils of four aromatic medicinal plants from Abaco Island, Bahamas. J. Herbs Spices Med. Plants 2006, 12, 43–65. [Google Scholar] [CrossRef]
  12. Setzer, W.N.; Vogler, B.; Schmidt, J.M.; Leahy, J.G.; Rives, R. Antimicrobial activity of Artemisia douglasiana leaf essential oil. Fitoterapia 2004, 75, 192–200. [Google Scholar] [CrossRef] [PubMed]
  13. Wright, B.S.; Bansal, A.; Moriarity, D.M.; Takaku, S.; Setzer, W.N. Cytotoxic leaf essential oils from Neotropical Lauraceae: Synergistic effects of essential oil components. Nat. Prod. Commun. 2007, 2, 1241–1244. [Google Scholar]
  14. Marei, G.I.K.; Abdel Rasoul, M.A.; Abdelgaleil, S.A.M. Comparative antifungal activities and biochemical effects of monoterpenes on plant pathogenic fungi. Pestic. Biochem. Physiol. 2012, 103, 56–61. [Google Scholar] [CrossRef]
  15. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J. Appl. Microbiol. 2003, 95, 853–860. [Google Scholar] [CrossRef] [PubMed]
  16. Aumeeruddy-Elalfi, Z.; Gurib-Fakim, A.; Mahomoodally, F. Antimicrobial, antibiotic potentiating activity and phytochemical profile of essential oils from exotic and endemic medicinal plants of Mauritius. Ind. Crops Prod. 2015, 71, 197–204. [Google Scholar] [CrossRef]
  17. Ahmad, A.; Khan, A.; Akhtar, F.; Yousuf, S.; Xess, I.; Khan, L.A.; Manzoor, N. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30, 41–50. [Google Scholar] [CrossRef] [PubMed]
  18. Marchese, A.; Orhan, I.E.; Daglia, M.; Barbieri, R.; Di Lorenzo, A.; Nabavi, S.F.; Gortzi, O.; Izadi, M.; Nabavi, S.M. Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chem. 2016, 210, 402–414. [Google Scholar] [CrossRef] [PubMed]
  19. Sharifi-Rad, M.; Varoni, E.M.; Iriti, M.; Martorell, M.; Setzer, W.N.; Contreras, M.D.M.; Salehi, B.; Soltani-Nejad, A.; Rajabi, S.; Tajbakhsh, M.; et al. Carvacrol and human health: A comprehensive review. Phyther. Res. 2018, in press. [Google Scholar] [CrossRef] [PubMed]
  20. Satyal, P.; Murray, B.L.; McFeeters, R.L.; Setzer, W.N. Essential oil characterization of Thymus vulgaris from various geographical locations. Foods 2016, 5, 70. [Google Scholar] [CrossRef] [PubMed]
  21. Pawar, V.C.; Thaker, V.S. In vitro efficacy of 75 essential oils against Aspergillus niger. Mycoses 2006, 49, 316–323. [Google Scholar] [CrossRef] [PubMed]
  22. Agarwal, V.; Lal, P.; Pruthi, V. Effect of plant oils on Candida albicans. J. Microbiol. Immunol. Infect. 2010, 43, 447–451. [Google Scholar] [CrossRef]
  23. Gayoso, C.W.; Lima, E.O.; Oliveira, V.T.; Pereira, F.O.; Souza, E.L.; Lima, I.O.; Navarro, D.F. Sensitivity of fungi isolated from onychomycosis to Eugenia cariophyllata essential oil and eugenol. Fitoterapia 2005, 76, 247–249. [Google Scholar] [CrossRef] [PubMed]
  24. Su, Y.-C.; Hsu, K.-P.; Ho, C.-L. Composition, in vitro cytotoxicity, and anti-mildew activities of the leaf essential oil of Machilus thunbergii from Taiwan. Nat. Prod. Commun. 2015, 10, 2013–2016. [Google Scholar] [PubMed]
  25. Yen, H.; Wang, S.-Y.; Wu, C.-C.; Lin, W.-Y.; Wu, T.-Y.; Chang, F.-R.; Wang, C.-K. Cytotoxicity, anti-platelet aggregation assay and chemical components analysis of thirty-eight kinds of essential oils. J. Food Drug Anal. 2012, 20, 478–483. [Google Scholar]
  26. Viollon, C.; Chaumont, J.-P. Antifungal properties of essential oils and their main components upon Cryptococcus neoformans. Mycopathologia 1994, 128, 151–152. [Google Scholar] [CrossRef] [PubMed]
  27. Tampieri, M.P.; Galuppi, R.; Macchioni, F.; Carelle, M.S.; Falcioni, L.; Cioni, P.L.; Morelli, I. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia 2005, 159, 339–345. [Google Scholar] [CrossRef] [PubMed]
  28. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol. 1999, 86, 985–990. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Jirovetz, L.; Buchbauer, G.; Denkova, Z.; Stoyanova, A.; Murgov, I.; Gearon, V.; Birkbeck, S.; Schmidt, E.; Geissler, M. Comparative study on the antimicrobial activities of different sandalwood essential oils of various origin. Flavour Fragr. J. 2006, 21, 465–468. [Google Scholar] [CrossRef]
  30. Ortiz, C.; Morales, L.; Sastre, M.; Haskins, W.E.; Matta, J. Cytotoxicity and genotoxicity assessment of sandalwood essential oil in human breast cell lines MCF-7 and MCF-10A. Evid.-Based Complement. Altern. Med. 2016, 2016, 3696232. [Google Scholar] [CrossRef] [PubMed]
  31. Santha, S.; Dwivedi, C. Anticancer effects of sandalwood (Santalum album). Anticancer Res. 2015, 35, 3137–3145. [Google Scholar] [PubMed]
  32. Santha, S.; Bommareddy, A.; Rule, B.; Guillermo, R.; Kaushik, R.S.; Young, A.; Dwivedi, C. Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis. PLoS ONE 2013, 8, e56982. [Google Scholar] [CrossRef]
  33. Bommareddy, A.; Crisamore, K.; Fillman, S.; Brozena, S.; Steigerwalt, J.; Landis, T.; Vanwert, A.L.; Dwivedi, C. Survivin down-regulation by α-santalol is not mediated through PI3K–AKT pathway in human breast cancer cells. Anticancer Res. 2015, 35, 5353–5357. [Google Scholar] [PubMed]
  34. Carmo, E.S.; Lima, E.D.O.; Souza, E.L.D.; Sousa, F.B.D. Effect of Cinnamomum zeylanicum Blume essential oil on the growth and morphogenesis of some potentially pathogenic Aspergillus species. Braz. J. Microbiol. 2008, 39, 91–97. [Google Scholar] [CrossRef] [PubMed]
  35. Giordani, R.; Regli, P.; Kaloustian, J.; Portugal, H. Potentiation of antifungal activity of amphotericin B by essential oil from Cinnamomum cassia. Phyther. Res. 2006, 20, 58–61. [Google Scholar] [CrossRef] [PubMed]
  36. Unlu, M.; Ergene, E.; Vardar, G.; Sivas, H.; Vural, N. Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae). Food Chem. Toxicol. 2010, 48, 3274–3280. [Google Scholar] [CrossRef] [PubMed]
  37. Bin Jantan, I.; Moharam, B.A.K.; Santhanam, J.; Abdul, B.; Moharam, K.; Santhanam, J.; Jamal, J.A. Correlation between chemical composition and antifungal activity of the essential oils of eight Cinnamomum species. Pharm. Biol. 2008, 46, 406–412. [Google Scholar] [CrossRef]
  38. Ferhout, H.; Bohatier, J.; Guillot, J.; Chalchat, J.C. Antifungal activity of selected essential oils, cinnamaldehyde and carvacrol against Malassezia furfur and Candida albicans. J. Essent. Oil Res. 1999, 11, 119–129. [Google Scholar] [CrossRef]
  39. Siegfried, S.A.; Schroeder, J.R. Toxicity of thieves oils to MCF-7 and MDA-MB-231 breast cancer cells. Am. J. Essent. Oils Nat. Prod. 2018, 6, 1–8. [Google Scholar]
  40. Kumari, P.; Mishra, R.; Arora, N.; Chatrath, A.; Gangwar, R.; Roy, P.; Prasad, R. Antifungal and anti-biofilm activity of essential oil active components against Cryptococcus neoformans and Cryptococcus laurentii. Front. Microbiol. 2017, 8, 2161. [Google Scholar] [CrossRef] [PubMed]
  41. Fang, S.; Rao, Y.K.; Tzeng, Y.-M. Cytotoxic effect of trans-cinnamaldehyde from Cinnamomum osmophloeum leaves on human cancer cell lines. Int. J. Appl. Sci. Eng. 2004, 2, 136–147. [Google Scholar]
  42. Pattnaik, S.; Subramanyam, V.R.; Bapaji, M.; Kole, C.R. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios 1997, 89, 39–46. [Google Scholar] [PubMed]
  43. Setzer, W.N.; Schmidt, J.M.; Eiter, L.C.; Haber, W.A. The leaf oil composition of Zanthoxylum fagara (L.) Sarg. from Monteverde, Costa Rica, and its biological activities. J. Essent. Oil Res. 2005, 17, 333–335. [Google Scholar] [CrossRef]
  44. O’Brien, P.J.; Siraki, A.G.; Shangari, N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 2005, 35, 609–662. [Google Scholar] [CrossRef] [PubMed]
  45. Sharopov, F.S.; Wink, M.; Khalifaev, D.R.; Zhang, H.; Dosoky, N.S.; Setzer, W.N. Composition and bioactivity of the essential oil of Melissa officinalis L. growing wild in Tajikistan. Int. J. Tradit. Nat. Med. 2013, 2, 86–96. [Google Scholar]
  46. Sharopov, F.S.; Valiev, A.K.; Satyal, P.; Setzer, W.N.; Wink, M. Chemical composition and anti-proliferative activity of the essential oil of Coriandrum sativum L. Am. J. Essent. Oils Nat. Prod. 2017, 5, 11–14. [Google Scholar]
  47. Kocevski, D.; Du, M.; Kan, J.; Jing, C.; Lačanin, I.; Pavlović, H. Antifungal effect of Allium tuberosum, Cinnamomum cassia, and Pogostemon cablin essential oils and their components against population of Aspergillus species. J. Food Sci. 2013, 78, M731–M737. [Google Scholar] [CrossRef] [PubMed]
  48. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry, 4th ed.; Allured Publishing: Carol Stream, IL, USA, 2007. [Google Scholar]
  49. Satyal, P. Development of GC-MS Database of Essential Oil Components by the Analysis of Natural Essential Oils and Synthetic Compounds and Discovery of Biologically Active Novel Chemotypes in Essential Oils. Ph.D. Thesis, University of Alabama in Huntsville, Huntsville, AL, USA, 2015. [Google Scholar]
  50. Dosoky, N.S. Isolation and Identification of Bioactive Compounds from Conradina canescens Gray. Ph.D. Thesis, University of Alabama in Huntsville, Huntsville, AL, USA, 2015. [Google Scholar]
  51. Reed, L.J.; Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27, 493–497. [Google Scholar]
Sample Availability: Samples of the compounds are not available from the authors.
Molecules 23 01549 g001 550
Figure 1. Dendrogram obtained from the agglomerative hierarchical cluster analysis of 60 essential oil compositions; antifungal and cytotoxic activities.
Figure 1. Dendrogram obtained from the agglomerative hierarchical cluster analysis of 60 essential oil compositions; antifungal and cytotoxic activities.
Molecules 23 01549 g001
Table
Table 1. Antifungal and cytotoxic activities and major components of sixty commercially-available essential oils. MIC—minimum inhibitory concentrations.
Table 1. Antifungal and cytotoxic activities and major components of sixty commercially-available essential oils. MIC—minimum inhibitory concentrations.
Essential Oil SourceAntifungal Activity (MIC, μg/mL)Cytotoxicity (IC50, μg/mL, Standard Deviations in Parentheses)Major Components (>5%)
A. nigerC. albicansC. neoformansMCF-7MDA-MB-231Others
Abies balsameaBalsam firAmeo125062531350.5 (15.0)86.7 (7.4) β-pinene (26.4%), δ-3-carene (18.3%), α-pinene (16.0%), sylvestrene (15.0%), bornyl acetate (9.7%), camphene (5.7%),
Abies sibiricaSiberian firdoTERRA625625156>100>100 camphene (24.8%), bornyl acetate (21.1%), α-pinene (15.2%), δ-3-carene (14.6%), limonene (5.7%)
Anthemis nobilisRoman chamomiledoTERRA625625313>100>100 α-pinene (15.5%), isobutyl angelate (12.6%), methallyl angelate (10.9%), 3-methylpentyl angelate (5.4%)
Betula lentaBirchdoTERRA625625625>100>100 methyl salicylate (99.9%)
Boswellia carteriFrankincenseAmeo625125031339.8 (4.1)50.6 (1.0) limonene (22.4%), β-caryophyllene (22.2%), p-cymene (10.0%), δ-cadinene (9.4%), α-copaene (4.8%)
Cananga odorataYlang ylangAmeo12506257836.8 (2.3)61.6 (4.4)50.4 (7.2) (Hs-578T)germacrene D (25.0%), β-caryophyllene (15.8%), (E,E)-α-farnesene (11.0%), benzyl benzoate (8.5%), geranyl acetate (5.2%)
Cinnamomum cassiaCassiadoTERRA78782014.0 (1.4)16.9 (1.0)16.4 (0.9) (Hep-G2)(E)-cinnamaldehyde (79.9%), (E)-o-methoxycinnamaldehyde (12.0%)
Cinnamomum zeylanicumCinnamondoTERRA78782013.3 (1.6)24.2 (1.5)25.2 (2.2) (Hep-G2)(E)-cinnamaldehyde (63.9%), eugenol (7.0%), (E)-cinnamyl acetate (5.1%)
Cistus ladaniferCistusAlbert Vielle62562515636.6 (3.0)71.1 (5.3)46.3 (4.0) (Hs-578T)α-pinene (20.8%), viridiflorene (10.9%),bornyl acetate (6.3%), viridoflorol (5.2%)
Citrus aurantifoliaLimedoTERRA62562531367.4 (5.9)40.3 (7.0) limonene (51.9%), β-pinene (18.8%), γ-terpinene (8.1%)
Citrus aurantiumPetitgraindoTERRA625625313>100>100 linalyl acetate (51.5%), linalool (25.4%)
Citrus bergamiaBergamotAmeo625625313>100>100 limonene (34.6%), linalyl acetate (34.3%), linalool (12.7%), γ-terpinene (6.6%), β-pinene (5.6%)
Citrus limonLemondoTERRA62562531394.8 (8.1)>100 limonene (56.1%), β-pinene (15.8%), γ-terpinene (10.5%)
Citrus reticulataTangerinedoTERRA62562515699.8 (10.0)54.8 (10.7) limonene (91.3%)
Citrus sinensisWild orangedoTERRA62562515687.4 (3.0)50.4 (11.0) limonene (94.8%)
Citrus × paradisiGrapefruitdoTERRA3136257879.7 (3.6)50.6 (8.7) limonene (91.3%)
Commiphora myrrhaMyrrhAmeo6251250313>10086.4 (8.5) furanoeudesma-1,3-diene (18.1%), curzerene (16.1%), lindestrene (6.9%), α-pinene (6.8%), neryl acetate (6.3%)
Copaifera officinalisCopaibaAmeo1250125031322.7 (1.5)67.2 (2.2) β-caryophyllene (87.3%)
Copaifera spp.CopaibadoTERRA625125062560.4 (1.9)59.8 (6.1) β-caryophyllene (50.0%), trans-α-bergamotene (8.5%), α-copaene (6.8%), α-humulene (6.0%)
Coriandrum sativumCilantrodoTERRA3133132042.8 (2.3)43.1 (3.9) linalool (29.8%), (2E)-decenal (25.9%), (2E)-decen-1-ol (10.6%), n-decanal (7.9%)
Coriandrum sativumCorianderdoTERRA625125062598.6 (4.4)>100 linalool (73.5%), α-pinene (5.3%)
Cupressus sempervirensCypressAmeo125062531334.5 (2.6)65.2 (1.5) α-pinene (49.7%), δ-3-carene (27.0%)
Cymbopogon flexuosusLemongrassdoTERRA3133137823.1 (1.4)30.7 (2.1) geranial (49.9%), neral (23.4%), geraniol (7.6%), geranyl acetate (6.4%)
Elettaria cardamomumCardamomdoTERRA625625156>100>100 α-terpinyl acetate (37.2%), 1,8-cineole (35.3%), linalyl acetate (5.0%)
Eucalyptus radiataEucalyptusdoTERRA313625156>100>100 1,8-cineole (78.8%), α-terpineol (8.6%)
Eugenia caryophyllataClovedoTERRA156313156>100>100 eugenol (80.6%), eugenyl acetate (10.5%), β-caryophyllene (6.5%)
Foeniculum vulgareFenneldoTERRA62562531395.9 (2.6)>100 (E)-anethole (75.1%), limonene (11.5%), fenchone (6.5%)
Gualtheria fragrantissimaWintergreendoTERRA625625625>100>100 methyl salicylate (99.7%)
Helichrysum italicumHelichrysumAmeo125062531344.8 (1.4)39.5 (5.7) neryl acetate (18.3%), α-pinene (18.0%), γ-curcumene (11.6%), β-selinene (10.3%), β-caryophyllene (6.1%), italicene (5.5%), valencene (5.1%)
Helichrysum italicumHelichrysumdoTERRA62562531381.8 (10.0)>100 neryl acetate (33.9%), γ-curcumene (14.7%), α-pinene (13.4%)
Juniperus communisJuniper berryAmeo6251250625>100>100 α-pinene (34.9%), myrcene (11.9%), sabinene (11.4%), β-pinene (7.9%), β-caryophyllene (5.1%)
Juniperus virginianaCedarwooddoTERRA62562531337.2 (2.2)35.7 (1.8) α-cedrene (41.4%), cis-thujopsene (20.0%), cedrol (13.4%), β-cedrene (7.5%)
Lavandula angustifoliaLavenderAmeo62562515694.7 (4.7)60.3 (17.3) linalyl acetate (41.5%), linalool (34.4%)
Melaleuca alternifoliaMelaleucadoTERRA625625625>100>100 terpinen-4-ol (47.5%), γ-terpinene (20.2%), α-terpinene (8.6%)
Melissa officinalisMelissadoTERRA3133137832.4 (2.5)28.1 (1.5) geranial (30.2%), neral (23.1%), β-caryophyllene (13.4%)
Mentha piperitaPeppermintdoTERRA625625313>100>100 menthol (43.8%), menthone (19.7%), menthyl acetate (6.5%), 1,8-cineole (5.0%)
Mentha spicataSpearmintdoTERRA313625313>100>100 carvone (62.3%), limonene (20.1%)
Myristica fragransNutmegAmeo62562515643.4 (0.3)32.6 (1.3) sabinene (18.8%), myristicin (18.2%), α-pinene (17.1%), β-pinene (11.4%), sylvestrene (5.6%)
Myrtis communisMyrtleAmeo125031378>100>100 α-pinene (46.1%), 1,8-cineole (27.5%), limonene (9.1%)
Nardostachys jatamansiSpikenarddoTERRA62531315635.5 (2.2)65.2 (3.2) viridiflorene (9.5%), 6,9-guaiadiene (8.8%), valeranone (7.8%), nardosina-7,9,11-triene (6.9%), β-gurjunene (6.7%), valerana-7,11-diene (6.2%), nardol (6.0%)
Nepeta catariaCatnipMountain Rose313625156>100>100 4aα,7α,7aβ-nepetalactone (58.1%), 4aα,7α,7aα- nepetalactone (20.6%), β-caryophyllene (6.8%)
Ocimum basilicumBasildoTERRA313625313>100>100 linalool (55.7%), 1,8-cineole (9.8%), trans-α-bergamotene (5.6%)
Origanum majoranaMarjoramdoTERRA625625313>100>100 terpinen-4-ol (28.9%), γ-terpinene (14.9%), trans-sabinene hydrate (9.5%), α-terpinene (8.7%), sabinene (7.2%)
Origanum vulgareOreganodoTERRA1563137835.3 (1.4)60.1 (17.3) carvacrol (74.2%), γ-terpinene (5.2%)
Pelargonium graveolensGeraniumAmeo625625625>100>100 citronellol (36.6%), iso-menthone (5.9%), geraniol (5.5%)
Picea marianaSpruceAmeo625625313>100>100 bornyl acetate (35.9%), camphene (14.5%), α-pinene (14.4%), δ-3-carene (8.2%)
Piper nigrumBlack pepperdoTERRA625125031387.7 (4.1)74.0 (3.0) β-caryophyllene (21.6%), limonene (15.1%), β-pinene (15.1%), sabinene (13.9%), α-pinene (11.1%), δ-3-carene (10.4%)
Pogostemon cablinPatchouliAmeo1566252025.0 (5.2)47.4 (1.1)22.6 (4.1) (Hep-G2)patchouli alcohol (36.4%), α-bulnesene (16.3%), α-guaiene (12.4%), seychellene (8.7%), α-patchoulene (5.6%)
Pseudotsuga menziesiiDouglas firdoTERRA625313156>100>100 β-pinene (23.0%), sabinene (17.3%), terpinolene (13.5%), δ-3-carene (9.6%), α-pinene (8.1%)
Rosmarinus officinalisRosemarydoTERRA625625313>100>100 1,8-cineole (45.9%), α-pinene (12.0%), camphor (10.9%), β-pinene (6.3%)
Salvia officinalisSageMountain Rose1250625625>100>100 cis-thujone (27.4%), camphor (21.4%), 1,8-cineole (11.9%), camphene (5.3%), α-pinene (5.2%)
Salvia sclareaClary sageAmeo1250125031398.4 (3.6)>100 linalyl acetate (69.0%)
Santalum albumIndian sandalwooddoTERRA313625209.39 (1.34)19.3 (0.2)14.2 (1.6) (Hep-G2)(Z)-α-santalol (45.2%), (Z)-β-santalol (25.4%), (Z)-α-trans-bergamotol (7.8%)
Santalum austrocaledonicumAustralian sandalwoodAmeo313625209.52 (0.08)20.4 (1.0)22.2 (1.4) (Hep-G2)(Z)-α-santalol (49.2%), (Z)-β-santalol (23.9%), (Z)-lanceol (6.4%)
Santalum paniculatumHawaiian sandalwooddoTERRA1566252013.3 (2.4)23.7 (2.1)29.6 (1.7) (Hep-G2)(Z)-α-santalol (49.9%), (Z)-β-santalol (15.9%), (Z)-lanceol (6.6%), (Z)-α-trans-bergamotol (5.1%)
Tanacetum annuumBlue tansydoTERRA625625156>100>100 sabinene (21.5%), myrcene (14.3%), camphor (12.0%), α-phellandrene (7.4%), p-cymene (5.8%), chamazulene (5.0%)
Thuja plicataArborvitaedoTERRA313787889.0 (6.3)>100 methyl thujate (51.2%), methyl myrtenate (6.6%)
Thymus vulgarisThymedoTERRA15631378>100>100 thymol (43.9%), carvacrol (14.4%), p-cymene (10.5%), β-caryophyllene (7.0%), γ-terpinene (5.1%)
Vetiveria zizanoidesVetiverdoTERRA783132023.9 (1.1)36.2 (0.8)20.2 (4.4) (Hep-G2)(E)-isovalencenol (13.5%), khusimol (12.1%), α-vetivone (5.4%)
Zingiber officinaleGingerdoTERRA625625313>10081.5 (5.9) α-zingiberene (26.4%), camphene (12.6%), β-sesquiphellandrene (9.2%), ar-curcumene (6.5%), β-phellandrene (6.2%), β-bisabolene (5.1%)

Share and Cite

MDPI and ACS Style

Powers, C.N.; Osier, J.L.; McFeeters, R.L.; Brazell, C.B.; Olsen, E.L.; Moriarity, D.M.; Satyal, P.; Setzer, W.N. Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils. Molecules 2018, 23, 1549. https://doi.org/10.3390/molecules23071549

AMA Style

Powers CN, Osier JL, McFeeters RL, Brazell CB, Olsen EL, Moriarity DM, Satyal P, Setzer WN. Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils. Molecules. 2018; 23(7):1549. https://doi.org/10.3390/molecules23071549

Chicago/Turabian Style

Powers, Chelsea N., Jessica L. Osier, Robert L. McFeeters, Carolyn Brianne Brazell, Emily L. Olsen, Debra M. Moriarity, Prabodh Satyal, and William N. Setzer. 2018. "Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils" Molecules 23, no. 7: 1549. https://doi.org/10.3390/molecules23071549

Article Metrics

Back to TopTop